Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dana Salgado

Optometrist Albany, NY Doctor of Optometry

NPI 1487666251 CMS profile 889250

1692 Central Ave, Albany, NY 12205

Open in the dashboard

General payments

$119,339

270 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dana Salgado of Albany, NY is reported in the CMS Open Payments database as having received $119,339 across 270 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $21,934 57
2024 General $67,185 110
2023 General $6,339 28
2022 General $6,619 21
2021 General $6,742 8
2020 General $7,843 24
2019 General $2,678 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dana Salgado
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Dana Salgado were reported at $21,934. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Dana Salgado Optometrist median Middle half National median
2019 $2,678 $159 $67–$371 $163
2020 $7,843 $72 $29–$165 $114
2021 $6,742 $125 $46–$292 $132
2022 $6,619 $162 $66–$374 $149
2023 $6,339 $177 $72–$406 $160
2024 $67,185 $188 $77–$427 $164
2025 $21,934 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bausch & Lomb Americas Inc. $101,305 209 payments
  2. Bausch & Lomb, a division of Bausch Health US, LLC $15,878 42 payments
  3. Johnson & Johnson Vision Care, Inc. $1,036 7 payments
  4. Sight Sciences, Inc. $273 2 payments
  5. Glaukos Corporation $258 2 payments
  6. Astellas Pharma US Inc $115 1 payment
  7. Alcon Vision LLC $115 1 payment
  8. Allergan Inc. $109 1 payment
  9. Johnson & Johnson Surgical Vision, Inc. $79 1 payment
  10. Visioneering Technologies, Inc. $68 1 payment
  11. Other $104 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $74,800 27 payments
  2. Travel and Lodging $23,277 108 payments
  3. Food and Beverage $7,150 123 payments
  4. Consulting Fee $7,145 5 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $5,950 4 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,000 2 payments
  7. Gift $17 1 payment
Products named General payments · program years 2019–2025
  1. INFUSE $84,049 171 payments
  2. INFUSE MULTIFOCAL $7,546 12 payments
  3. ULTRA MULTIFOCAL TORIC $7,197 13 payments
  4. ULTRA $4,749 22 payments
  5. BIOTRUE $3,988 14 payments
  6. BIOTRUE ONE DAY $3,510 18 payments
  7. Acuvue $1,036 7 payments
  8. OMNI SURGICAL SYSTEM $273 2 payments
  9. MIEBO $120 1 payment
  10. Clareon PanOptix Pro $115 1 payment
  11. Other $542 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

270 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record